Nonsteroidal antiinflammatory drugs, eicosanoids, and colorectal cancer prevention

Gastroenterology Clinics of North America

Volumn 25, Issue 4, 1996, Pages 773-791

  DuBois, R N ^a   Giardiello, F M ^a   Smalley, W E ^a  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ICOSANOID; INDOMETACIN; MECLOFENAMIC ACID; NONSTEROID ANTIINFLAMMATORY AGENT; PIROXICAM; SULINDAC; ANTINEOPLASTIC AGENT;

ADENOMATOUS POLYP; ANIMAL MODEL; CANCER INCIDENCE; CANCER PREVENTION; CLINICAL TRIAL; COLORECTAL CANCER; HUMAN; NONHUMAN; REVIEW; ANIMAL; CASE CONTROL STUDY; COLON POLYPOSIS; COLORECTAL TUMOR; DISEASE MODEL; INCIDENCE; MOUSE; PROSPECTIVE STUDY; RAT; RETROSPECTIVE STUDY;

ADENOMATOUS POLYPOSIS COLI; ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTICARCINOGENIC AGENTS; ASPIRIN; CASE-CONTROL STUDIES; CLINICAL TRIALS; COLORECTAL NEOPLASMS; DISEASE MODELS, ANIMAL; EICOSANOIDS; HUMANS; INCIDENCE; MICE; PROSPECTIVE STUDIES; RATS; RETROSPECTIVE STUDIES; SULINDAC;

EID: 0030299879     PISSN: 08898553     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0889-8553(05)70274-0     Document Type: Article

References (87)

1. A. Bedi P.J. Pasricha A.J. Akhtar Inhibition of apoptosis during development of colorectal cancer Cancer Res 55 1995 1811 1816
2. C.R. Boland The biology of colorectal cancer: Implications for pretreatment and follow-up management Cancer 71 1993 4180 4186
3. 2 synthase are markedly affected by glutathione and glutathione peroxidase(s) Biochemistry 34 1995 3325 3337
4. R.N. DuBois Nonsteroidal anti-inflammatory drug use and sporadic colorectal adenomas Gastroenterology 108 1995 1310 1314
5. R.N. DuBois A. Radhika B.S. Reddy Increased cyclooxygenase-2 levels in carcinogen-induced rat colonic tumors Gastroenterology 110 1996 1259 1262
6. R.N. DuBois M. Tsujii P. Bishop Cloning and characterization of a growth factor–inducible cyclooxygenase gene from rat intestinal epithelial cells Am J Physiol 266 1994 G822 G827
7. C.E. Eberhart R.J. Coffey A. Radhika Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas Gastroenterology 107 1994 1183 1188
8. E.R. Fearon Molecular genetic studies of the adenoma-carcinoma sequence Adv Int Med 39 1994 123 147
9. E.R. Fearon B. Vogelstein A genetic model for colorectal tumorigenesis Cell 61 1990 759 767
10. F.M. Giardiello S.R. Hamilton A.J. Krush Treatment of colonic and rectal adenomas with sulindac in familial adenomatous polyposis N Engl J Med 328 1993 1313 1316
11. E. Giovannucci K.M. Egan D.J. Hunter Aspirin and the risk of colorectal cancer in women N Engl J Med 333 1995 609 614
12. E. Giovannucci E.B. Rimm M.J. Stampfer Aspirin use and the risk for colorectal cancer and adenoma in male health professionals Ann Intern Med 121 1994 241 246
13. E.R. Greenberg J.A. Baron D.H.J. Freeman Reduced risk of large-bowel adenomas among aspirin users: The Polyp Prevention Study Group J Natl Cancer Inst 85 1993 912 916
14. S.R. Hamilton The molecular genetics of colorectal neoplasia Gastroenterology 105 1993 3 7
15. L.J. Hixson D.S. Alberts M. Krutzsch Antiproliferative effect of nonsteroidal antiinflammatory drugs against human colon cancer cells Cancer Epidemiol Biomarkers Prev 3 1994 433 438
16. L.J. Hixson D.L. Earnest M.B. Fennerty NSAID effect on sporadic colon polyps Am J Gastroenterol 88 1993 1652 1656
17. T. Hla K. Neilson Human cyclooxygenase-2 cDNA Proc Natl Acad Sci USA 89 1992 7384 7388
18. M.J. Holtzman J. Turk L.P. Shornick Identification of a pharmacologically distinct prostaglandin H synthase in cultured epithelial cells J Biol Chem 267 1992 21438 21445
19. R.F. Jacoby D.J. Marshall M.A. Newton Chemoprevention of spontaneous intestinal adenomas in the ApcMin mouse model by the nonsteroidal anti-inflammatory drug piroxicam Cancer Res 56 1996 710 714
20. D.A. Jones D.P. Carlton T.M. McIntyre Molecular cloning of human prostaglandin endoperoxide synthase type II and demonstration of expression in response to cytokines J Biol Chem 268 1993 9049 9054
21. S. Kargman G. O'Neill P. Vickers Expression of prostaglandin G/H synthase-1 and -2 protein in human colon cancer Cancer Res 55 1995 2556 2559
22. K.W. Kinzler M.C. Nilbert L.K. Su Identification of FAP locus genes from chromosome 5q21 Science 253 1991 661 665
23. T. Kudo T. Narisawa S. Abo Antitumor activity of indomethacin on methylazoxymethanol-induced large bowel tumors in rats Gann 71 1980 260 264
24. D.A. Kujubu B.S. Fletcher B.C. Varnum TIS10, a phorbol ester tumor promoter- inducible mRNA from Swiss 3T3 cells, encodes a novel prostaglandin synthase/cyclooxygenase homologue J Biol Chem 266 1991 12866 12872
25. K.A. Kune S. Kune L.F. Watson Colorectal cancer risk, chronic illnesses, operations, and medications: Case control results from the Melbourne Colorectal Cancer Study Cancer Res 48 1988 4399 4404
26. D. Labayle D. Fischer P. Vielh Sulindac causes regression of rectal polyps in familial adenomatous polyposis Gastroenterology 101 1991 635 639
27. J. Landenheim G. Garcia D. Titzer Effect of sulindac on sporadic colonic polyps Gastroenterology 108 1995 1083 1087
28. D.B. Levy K.J. Smith Y. Beazer-Barclay Inactivation of both APC alleles in human and mouse tumors Cancer Res 54 1994 5953 5958
29. T. Liu A.O. Mokuolu C.V. Rao Regional chemoprevention of carcinogen-induced tumors in rat colon Gastroenterology 109 1995 1167 1172
30. R.F. Logan J. Little P.G. Hawtin Effect of aspirin and nonsteroidal anti-inflammatory drugs on colorectal adenomas: Case-control study of subjects participating in the Nottingham faecal occult blood screening programme BMJ 307 1993 285 289
31. C. Luongo A.R. Moser S. Gledhill Loss of Apc+ in intestinal adenomas from Min mice Cancer Res 54 1994 5947 5952
32. min-induced intestinal neoplasia Cell 81 1995 957 966
33. L. Marnett Aspirin and the potential role of prostaglandins in colon cancer Cancer Res 52 1992 5575 5589
34. E.A. Meade W.L. Smith D.L. DeWitt Differential inhibition of prostaglandin endoperoxide synthase (cyclooxygenase) isozymes by aspirin and other non-steroidal anti-inflammatory drugs J Biol Chem 268 1993 6610 6614
35. U. Metzger J. Meier G. Uhlschmid Influence of various prostaglandin synthesis inhibitors on DMH-induced rat colon cancer Dis Colon Rectum 27 1984 366 369
36. A.B. Miller G.R. Howe M. Jain Food items and food groups as risk factors in a case-control study of diet and colon cancer Int J Cancer 32 1983 155 162
37. M. Moorghen P. Ince K.J. Finney A protective effect of sulindac against chemically-induced primary colonic tumours in mice J Pathol 156 1988 341 347
38. M. Moorghen P. Ince K.J. Finney The effect of sulindac on colonic tumour formation in dimethylhydrazine-treated mice Acta Histochem 39 suppl 1990 195 1990
39. A.R. Moser H.C. Pitot W.F. Dove A dominant mutation that predisposes to multiple intestinal neoplasia in the mouse Science 247 1990 322 325
40. J.E. Muscat S.D. Stellman E.L. Wynder Nonsteroidal antiinflammatory drugs and colorectal cancer Cancer 74 1994 1847 1854
41. J.E. Muscat E.L. Wynder Anti-inflammatory drugs and rheumatoid arthritis J Natl Cancer Inst 85 1993 921 922
42. 2) against indomethacin J Cancer Res Clin Oncol 108 1984 239 242
43. T. Narisawa M. Sato M. Sano Inhibition of development of methylnitrosourea-induced rat colonic tumors by peroral administration of indomethacin Gann 73 1982 377 381
44. T. Narisawa M. Satoh M. Sano Inhibition of initiation and promotion by N-methylnitrosourea-induced colon carcinogenesis in rats by non-steroid anti-inflammatory agent indomethacin Carcinogenesis 4 1983 1225 1227
45. N.D. Nigro A.W. Bull M.E. Boyd Inhibition of intestinal carcinogenesis in rats: Effect of difluoromethylornithine with piroxicam or fish oil J Natl Cancer Inst 77 1986 1309 1313
46. I. Nishisho Y. Nakamura Y. Miyoshi Mutations of chromosome 5q21 genes in FAP and colorectal cancer patients Science 253 1991 665 669
47. K.P. Nugent K.C. Farmer A.D. Spigelman Randomized controlled trial of the effect of sulindac on duodenal and rectal polyposis and cell proliferation in patients with familial adenomatous polyposis Br J Surg 80 1993 1618 1619
48. M. Oshima H. Oshima K. Kitagawa Loss of Apc heterozygosity and abnormal tissue building in nascent intestinal polyps in mice carrying a truncated Apc gene Proc Natl Acad Sci USA 92 1995 4482 4486
49. A. Paganini-Hill A. Chao R.K. Ross Aspirin use and chronic diseases: A cohort study of the elderly BMJ 299 1989 1247 1250
50. L.A. Peipins R.S. Sandler Epidemiology of colorectal adenomas Epidemiol Rev 16 1994 273 297
51. I.I. Peleg H.T. Maibach S.H. Brown Aspirin and nonsteroidal anti-inflammatory drug use and the risk of subsequent colorectal cancer Arch Intern Med 154 1994 394 399
52. Physicians' Health Study Group Final report on the aspirin component of the ongoing Physicians' Health Study N Engl J Med 321 1989 129 135
53. Physician's Health Study Group Preliminary report: Findings from the aspirin component of the ongoing Physician's Health Study N Engl J Med 318 1995 262 264
54. M. Pollard P.H. Luckert Indomethacin treatment of rats with dimethylhydrazine-induced intestinal tumors Cancer Treat Rep 64 1980 1323 1327
55. M. Pollard P.H. Luckert Effect of indomethacin on intestinal tumors induced in rats by the acetate derivative of dimethylnitrosamine Science 214 1981 558 559
56. M. Pollard P.H. Luckert Prolonged antitumor effect of indomethacin on autochthonous intestinal tumors in rats J Natl Cancer Inst 70 1983 1103 1105
57. M. Pollard P.H. Luckert Effect of piroxicam on primary intestinal tumors induced in rats by N-methylnitrosourea Cancer Lett 25 1984 117 121
58. M. Pollard P.H. Luckert In vivo model systems for assessing an anti-cancer drug: Responses of autochthonous and transplanted prostate tumors to cyclophosphamide Anticancer Res 10 1990 33 36
59. M. Pollard P.H. Luckert M.A. Schmidt The suppressive effect of piroxicam on autochthonous intestinal tumors in the rat Cancer Lett 21 1983 57 61
60. S.M. Powell N. Zilz Y. Beazer-Barclay APC mutations occur early during colorectal tumorigenesis Nature 359 1992 235 237
61. C.V. Rao A. Rivenson B. Simi Chemoprevention of colon carcinogenesis by sulindac, a nonsteroidal anti-inflammatory agent Cancer Res 55 1995 1464 1472
62. C.V. Rao K. Tokumo J. Rigotty Chemoprevention of colon carcinogenesis by dietary administration of piroxicam, alpha-difluoromethylornithine, 16 alpha-fluoro-5-androsten-17-one, and ellagic acid individually and in combination Cancer Res 51 1991 4528 4534
63. B.S. Reddy H. Maruyama G. Kelloff Dose-related inhibition of colon carcinogenesis by dietary piroxicam, a nonsteroidal antiinflammatory drug, during different stages of rat colon tumor development Cancer Res 47 1987 5340 5346
64. B.S. Reddy J. Nayini K. Tokumo Chemoprevention of colon carcinogenesis by concurrent administration of piroxicam, a nonsteroidal antiinflammatory drug with D, L-alpha-difluoromethylornithine, an ornithine decarboxylase inhibitor, in diet Cancer Res 50 1990 2562 2568
65. B.S. Reddy C.V. Rao A. Rivenson Inhibitory effect of aspirin on azoxymethane-induced colon carcinogenesis in F344 rats Carcinogenesis 14 1993 1493 1497
66. B.S. Reddy K. Tokumo N. Kulkarni Inhibition of colon carcinogenesis by prostaglandin synthesis inhibitors and related compounds Carcinogenesis 13 1992 1019 1023
67. J. Rigau J.M. Pique E. Rubio Effects of long-term sulindac therapy on colonic polyposis Ann Intern Med 115 1991 952 954
68. L. Rosenberg J.R. Palmer A.G. Zauber A hypothesis: Nonsteroidal anti-inflammatory drugs reduce the incidence of large-bowel cancer J Natl Cancer Inst 83 1991 355 358
69. D.S. Ross D. Bitzer T. Roy Piroxicam inhibits the growth of an adenocarcinoma isograft in Fischer rats J Surg Res 45 1988 249 253
70. A.K. Rustgi Molecular genetics and colorectal cancer Gastroenterology 104 1993 1223 1225
71. H. Sano Y. Kawahito R.L. Wilder Expression of cyclooxygenase-1 and -2 in human colorectal cancer Cancer Res 55 1995 3785 3789
72. D.M. Schreinemachers R.B. Everson Aspirin use and lung, colon, and breast cancer incidence in a prospective study Epidemiology 5 1994 138 146
73. T. Shimokawa W.L. Smith Prostaglandin endoperoxide synthase: The aspirin acetylation region J Biol Chem 267 1992 12387 12392
74. S.A. Skinner A.G. Penney P.E. O'Brien Sulindac inhibits the rate of growth and appearance of colon tumors in the rat Arch Surg 126 1991 1094 1096
75. W.L. Smith L.J. Marnett Prostaglandin endoperoxide synthase: Structure and catalysis Biochim Biophys Acta 1083 1991 1 17
76. L.K. Su K.W. Kinzler B. Vogelstein Multiple intestinal neoplasia caused by a mutation in the murine homolog of the APC gene Science 256 1992 668 670
77. L.K. Su B. Vogelstein K.W. Kinzler Association of the APC tumor suppressor protein with catenins Science 262 1993 1734 1737
78. O. Suh C. Mettlin N.J. Petrelli Aspirin use, cancer, and polyps of the large bowel Cancer 72 1993 1171 1177
79. M.J. Thun M.M. Namboodiri C.W.J. Heath Aspirin use and reduced risk of fatal colon cancer N Engl J Med 325 1991 1593 1596
80. F. Tonelli R. Valanzano Sulindac in familial adenomatous polyposis Lancet 342 1993 1120
81. J. Vane Towards a better aspirin Nature 367 1994 215 216
82. W.R. Waddell G.F. Gasner E.J. Cerise Sulindac for polyposis of the colon Am J Surg 157 1989 175 178
83. W.R. Waddell R.W. Loughry Sulindac for polyposis of the colon J Surg Oncol 24 1983 83 87
84. C.W. Williams R.N. DuBois Prostaglandin endoperoxide synthase: Why two isoforms? Am J Physiol 270 1996 G393 G400
85. G. Winde H.G. Gumbinger H. Osswald The NSAID sulindac reverses rectal adenomas in colectomized patients with familial adenomatous polyposis: Clinical results of a dose-finding study on rectal sulindac administration Int J Colorectal Dis 8 1993 13 17
86. E.L. Wynder T. Kajitani S. Ishikawa Environmental factors of cancer of colon and rectum: II. Japanese epidemiological data Cancer 23 1969 1210 1220
87. C. Yokoyama T. Tanabe Cloning of human gene encoding prostaglandin endoperoxide synthase and primary structure of the enzyme Biochem Biophys Res Commun 165 1989 888 894